Bender Robert & Associates Astrazeneca PLC Transaction History
Bender Robert & Associates
- $455 Million
- Q2 2024
A detailed history of Bender Robert & Associates transactions in Astrazeneca PLC stock. As of the latest transaction made, Bender Robert & Associates holds 16,875 shares of AZN stock, worth $1.31 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
16,875
Previous 18,813
10.3%
Holding current value
$1.31 Million
Previous $1.27 Million
3.3%
% of portfolio
0.29%
Previous 0.3%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,334Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.03 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.3 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.14 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.84 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.36 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...